Filing Details

Accession Number:
0001567619-20-019112
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-10 19:02:46
Reporting Period:
2020-11-06
Accepted Time:
2020-11-10 19:02:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219445 P Brian Mckeon One Idexx Drive
Westbrook ME 04092
Executive Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-06 21 $472.88 28,029 No 4 S Indirect by Estony McKeon Family, LLC
Common Stock Disposition 2020-11-06 1,241 $474.14 26,788 No 4 S Indirect by Estony McKeon Family, LLC
Common Stock Disposition 2020-11-06 3,338 $475.02 23,450 No 4 S Indirect by Estony McKeon Family, LLC
Common Stock Disposition 2020-11-06 300 $475.50 23,150 No 4 S Indirect by Estony McKeon Family, LLC
Common Stock Disposition 2020-11-06 2,100 $476.89 21,050 No 4 S Indirect by Estony McKeon Family, LLC
Common Stock Disposition 2020-11-06 3,000 $478.13 18,050 No 4 S Indirect by Estony McKeon Family, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Estony McKeon Family, LLC
No 4 S Indirect by Estony McKeon Family, LLC
No 4 S Indirect by Estony McKeon Family, LLC
No 4 S Indirect by Estony McKeon Family, LLC
No 4 S Indirect by Estony McKeon Family, LLC
No 4 S Indirect by Estony McKeon Family, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24,700 Direct
Footnotes
  1. Represents the weighted average price of the shares sold ranging from a low of $472.36 to a high of $473.36 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. Represents the weighted average price of the shares sold ranging from a low of $473.42 to a high of $474.32 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  3. Represents the weighted average price of the shares sold ranging from a low of $474.38 to a high of $475.32 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  4. Represents the weighted average price of the shares sold ranging from a low of $476.51 to a high of $477.61 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  5. Represents the weighted average price of the shares sold ranging from a low of $477.86 to a high of $478.26 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.